Your search returned 2 results.

Results
	1.	The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma. [electronic resource] by Esteve-Arenys, A Valero, J G Chamorro-Jorganes, A Gonzalez, D Rodriguez, V Dlouhy, I Salaverria, I Campo, E Colomer, D Martinez, A Rymkiewicz, G Pérez-Galán, P Lopez-Guillermo, A Roué, G Producer: 20190307 In: Oncogene vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma. [electronic resource] by Balsas, P Esteve-Arenys, A Roldán, J Jiménez, L Rodríguez, V Valero, J G Chamorro-Jorganes, A de la Bellacasa, R Puig Teixidó, J Matas-Céspedes, A Moros, A Martínez, A Campo, E Sáez-Borderías, A Borrell, J I Pérez-Galán, P Colomer, D Roué, G Producer: 20171128 In: Journal of hematology & oncology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search